Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 10, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	61	35	31	65	101	157
Market Cap Growth	64.63%	15.79%	-53.08%	-35.69%	-35.43%	637.70%
Enterprise Value	51	27	12	44	87	139
Last Close Price	0.06	0.04	0.04	0.08	0.15	0.24
PS Ratio	14.30	8.13	8.24	26.86	53.68	132.49
PB Ratio	3.59	3.11	1.69	2.50	6.05	7.69
P/TBV Ratio	3.98	3.64	1.86	2.87	7.57	9.21
EV/Sales Ratio	12.07	6.21	3.28	18.23	45.86	116.91
Debt / Equity Ratio	0.02	-	0.02	-	-	0.01
Net Debt / Equity Ratio	-0.56	-0.61	-0.78	-0.84	-0.73	-0.78
Net Debt / EBITDA Ratio	-	0.92	1.97	2.94	2.36	3.76
Net Debt / FCF Ratio	1.19	0.96	1.92	3.54	2.85	4.02
Asset Turnover	0.24	0.25	0.15	0.11	0.10	0.07
Quick Ratio	12.10	3.75	7.95	12.09	17.31	33.72
Current Ratio	12.95	4.08	8.08	12.21	17.61	34.19
Return on Equity (ROE)	-54.33%	-49.72%	-37.32%	-32.70%	-27.52%	-26.25%
Return on Assets (ROA)	-31.75%	-26.95%	-18.52%	-20.39%	-16.88%	-16.05%
Return on Capital Employed (ROCE)	-51.80%	-66.10%	-39.80%	-28.60%	-31.00%	-20.70%
Earnings Yield	-14.53%	-20.66%	-26.92%	-10.74%	-5.05%	-2.64%
FCF Yield	-	-20.44%	-24.17%	-9.49%	-4.26%	-2.53%
Buyback Yield / Dilution	-12.27%	-	-10.69%	-12.31%	-5.88%	-55.18%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.